Sep 2026· Russian journal of general chemistry· Vol 96· 0 citations· 27 references
TL;DR
The results demonstrated that the DFT-optimized molecular structure is in good agreement with the crystal structure measured by X-ray single-crystal diffraction, thereby validating the reliability of the theoretical calculations.
The obtained findings demonstrated potential of 2-benzylaminothienopyrimidin-4(3H)-ones as promising scaffolds for further development of anticancer agents.
N. Pokhodylo, Kostiantyn V. Levchenko, N. Finiuk et al.· Medicinal Chemistry Research· 0 citations
A novel retrosynthetic strategy based on the stepwise construction of the tricyclic core from readily available 5- aminopyrazoles is proposed, providing medicinal chemists with a valuable toolkit for developing new bioactive entities.
Christian A. Becerra R, Juan D. Alarcón F, Paola A. Cuervo P et al.· Mini-Reviews in Medical Chem...· 0 citations
All newly synthesized thiazolidine-2,4-dione derivatives showed encouraging therapeutic potential according to in silico studies, suggesting that they might be a possible therapeutic target.
Bushra Ansari, M. S. Jan, Abdul Saboor Pirzada et al.· Scientific Reports· 0 citations
Among the newly synthesized scaffolds, the isothiazolo[3,4-b]pyrazines were the most promising, displaying potent and selective PIKfyve inhibition in a biochemical assay, and, in addition, showing antiviral activity against SARS-CoV-2 (in the low μM range).
Ling-Jie Gao, M. Froeyen, Chieh-Wen Lo et al.· Bioorganic chemistry (Print)· 0 citations
Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.
Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al.· RSC Advances· 0 citations
The combined computational and biological data suggest that these hydrazinoquinoline derivatives, especially those with electron-withdrawing substituents, hold promise as lead structures for further development in liver cancer therapy targeting EGFR.
Swezel Negredo, B. Biradar, Soniya Phadte et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.